Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

108results about How to "Reduction in sign" patented technology

Multi-Active Microtargeted Anti-Aging Skin Cream Polymer Technology

InactiveUS20110305737A1Reduction in signWithout exacerbating acneCosmetic preparationsBiocideCosmetic creamLotion
A comprehensive, single agent cosmetic cream or lotion containing a high number of ingredients that target anti-aging in a defined manner. The cream or lotion contains a high number and variety of active substances that demonstrate excellent safety and efficacy in all of the various defined categories of skin aging, including but not limited to wrinkles, abnormal pigment or brown spots due to aging of the skin and an unexpectedly high efficacy in the reduction of redness and acne and rosacea blemishes.
Owner:MACRENE ACTIVES LLC

Antioxidants in clusters of structured water

The invention relates to structured water and its antioxidant activity. In addition, the present invention relates to antioxidants incorporated within the cluster structure of either electropositive (S water) or electronegative (I water). The structured water, having the antioxidant within its cluster structure, has a stabilizing effect on the antioxidant. In addition, the antioxidant activity inherent to structured water is enhanced by the presence of the antioxidant within its cluster structure. The present invention also includes methods of removing or reducing free radicals on the skin and thereby preventing the signs of skin aging and the risks of cancer associated with the presence of free radicals in the skin.
Owner:COLOR ACCESS

Compositions and methods of their use for improving the condition and appearance of skin

The present invention relates to compositions and methods for treating, preventing and improving the condition and / or aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating fine lines and / or wrinkles of skin, where the compositions include active agents which increase expression levels of genes associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and / or aesthetic appearance of skin.
Owner:AVON PROD INC

Topical dermal formulations

An autologous topical formulation containing conditioned medium obtained from culture of autologous fibroblasts has been developed. Unlike other topical formulations, it is autologous since it is derived solely from cells obtained by the person who is to use the formulation. This avoids any possible reaction with proteins derived from the cells. Preferred formulations include gels, creams, lotions, and ointments. The topical formulations of conditioned medium obtained by culturing autologous dermal fibroblasts are topically administered to individuals for the prevention and treatment of scarring, reduction in signs of aging, and improvement in quality of skin.
Owner:CASTLE CREEK BIOSCIENCES LLC

Compositions and methods of their use for improving the condition and appearance of skin

The present invention relates to compositions and methods for treating, preventing and improving the condition and / or aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating fine lines and / or wrinkles of skin, where the compositions include active agents which increase expression levels of genes associated with the dermatological signs of aging. The compositions of the invention are topically applied to the skin, or are delivered by directed means to a site in need thereof, once daily in an amount effective in improving the condition and / or aesthetic appearance of skin.
Owner:AVON PROD INC

Topical Dermal Formulations

An autologous topical formulation containing conditioned medium obtained from culture of autologous fibroblasts has been developed. Unlike other topical formulations, it is autologous since it is derived solely from cells obtained by the person who is to use the formulation. This avoids any possible reaction with proteins derived from the cells. Preferred formulations include gels, creams, lotions, and ointments. The topical formulations of conditioned medium obtained by culturing autologous dermal fibroblasts are topically administered to individuals for the prevention and treatment of scarring, reduction in signs of aging, and improvement in quality of skin.
Owner:CASTLE CREEK BIOSCIENCES LLC

Multi-active microtargeted anti-aging skin care cream polymer technology

A comprehensive, single agent cosmetic cream or lotion containing a high number of ingredients that target anti-aging in a defined manner. The cream or lotion contains a high number and variety of active substances that demonstrate excellent safety and efficacy in all of the various defined categories of skin aging, including but not limited to wrinkles, abnormal pigment or brown spots due to aging of the skin and an unexpectedly high efficacy in the reduction of redness and acne and rosacea blemishes.
Owner:MACRENE ACTIVES LLC

System and methods for promoting health

InactiveUS20080070210A1Structural degradationImmediate resultChiropractic devicesVibration massageBone densitySacroiliac joint
A system made up of methods and techniques designed to improve the body's postural alignment, joint range, muscle hydration, bone density, and overall musculoskeletal health. The system combines a series of exercised designed to lengthen and strengthen muscles, fascial and myofascial tissue. The system is used in combination with a vibrating roller device, which can also be used with a head cradle. The application of the vibrational motion to the body in combination with the techniques described herein work to stimulate fascial tissue and confer benefits on the user which will improve the overall quality of life.
Owner:HITZMANN SUE

Dietary supplement for enhancing animal health

InactiveUS20130216521A1Decrease clinical sign of diseaseShorten courseBiocidePeptide/protein ingredientsAntioxidantDietary supplement
A dietary supplement system including three general components is provided. The first component is the fatty acid component and this includes sunflower seeds (containing omega 6 fatty acids), flax seed (containing omega 3 fatty acids) and powdered oils (containing omega 3 or omega 6 fatty acids and generally produced from sunflower oils). The weight ratio of omega 6 fatty acids to omega 3 fatty acids is 10:1 to 1:1, with 10:1 to 5:1 being preferred for normal animals and 2:1 to 1:1 being preferred for animals which have fatty acid responsive conditions. The second component is the GI component, which is used for facilitating animal gut health. This component includes prebiotics, probiotics and immunoglobulin (typically from albumin concentrate). The third component is the breed specific component and can include vitamins, minerals, additional fatty acids, antioxidants, amino acids, palatants, and nutraceutical additives.
Owner:HARTZ MOUNTAIN

Use of Alisma orientale in cosmetics and compositions thereof

The present invention describes compositions and methods for improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating excess accumulation or production of subcutaneous fat, such as cellulite, or conditions related to excess accumulation, production, or excretion of sebum, such as acne, an oily complexion, oily hair or scalp, or undesirable body odor, by topically applying compositions comprising Alisma orientate constituents, or extracts therefrom.
Owner:AVON PROD INC

Aqueous, non-alcoholic liquid powder formulations

InactiveUS20060057217A1Reducing skin surface moistureReduce oilCosmetic preparationsPowder deliveryPolymer chemistryPolymer
The present invention is an aqueous, non-alcoholic liquid powder formulation. The aqueous, non-alcoholic liquid powder formulation comprises from about 14% to about 75% by weight of the formulation of water, from about 25% to about 60% by weight of the formulation of a powder, from about 0.05% to about 1% by weight of the formulation of a polymeric emulsifier, from about 0.5% to about 15% by weight of the formulation of a low molecular weight silicone wherein the low molecular weight silicone has an average molecular weight of about 10,000 or less, and from about 0.1% to about 10% by weight of the formulation of a high molecular weight silicone wherein the high molecular weight silicone has an average molecular weight of about 100,000 or greater. The aqueous, non-alcoholic liquid powder formulation may have an optical uniformity index of about 0.1 or less. The aqueous, non-alcoholic liquid powder formulation may have an extensive uniformity index of about 300 or greater.
Owner:KIMBERLY-CLARK WORLDWIDE INC

Cosmetic or dermopharmaceutical compositions of ceramides and polypeptides

Personal care products including cosmetics, grooming products and topical pharmaceutical products can be produced including a polypeptide of between 3 and 12 amino acids in length and a ceramide. These formulations are particularly useful in addressing wrinkles in human subjects and in particular facial skin and hands. Certain analogs and derivatives of these polypeptides may be used in these formulations and / or alone. Methods of using these formulations are also disclosed.
Owner:SEDERMA SA

Kit comprising ranges of cosmetics and a system for analyzing skin lightness level

The present invention provides a kit comprising: a plurality of ranges of cosmetic products, each range containing a set of products associated with a common level of skin lightness, the level of lightness being identified by an identifier; and an analysis system for analyzing at least one image of the skin, and configured to deliver an identifier representative of the lightness level of the analyzed skin, the identifier being one of the identifiers of said ranges of products.
Owner:LOREAL SA

Combined treatment of multiple sclerosis

The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and / or other demyelinating diseases is disclosed. Disclosed are also pharmaceutical compositions for treating multiple sclerosis and / or other demyelinating diseases. Disclosed are also pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage of EP0003504 of GH together with IFN-β to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.
Owner:LAB SERONO SA

Skin care compositions

This invention provides compositions and methods of manufacturing such compositions that employ GRAS compounds which can act to promote the generation of stem, epidermal or other skin cells in the epidermis, activation of collagen synthesis, activation of hyaluronic acid synthesis, enhanced skin hydration, and dermal healing by stimulating stem cell and fibroblast migration to sites of needed repair. These compositions and methods are useful for rejuvenating the skin and for treating some skin-related aging or other dermal damaging conditions, including wrinkle reduction and treatment of minor dermal wounds.
Owner:FLAVIN DANA +1

Methods for treating skin

Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and / or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.
Owner:AVON PROD INC

Modified live vaccine of mycoplasma bovis, methods of producing modified live mycoplasma bovis vaccines, combination vaccines and methods of treatment

The present invention relates to new attenuated M. bovis bacteria strains passaged at least 110 times. Moreover, the present invention also provides immunogenic compositions comprising live bacteria of any of those attenuated M. bovis bacteria strain, their manufacture and use for the treatment and prophylaxis of M. bovis infections and combinations with other veterinary vaccines or medicaments.
Owner:BOEHRINGER LNGELHEIM VETMEDICA GMBH

Method for the three-dimensional viewing of tomosynthesis images in mammography

In a method for the 3D viewing of tomosynthesis images in mammography, an algorithm is proposed for the viewing of radiology signs in series of 3D data. When the digital volume is being viewed by a practitioner, the disclosed algorithm is used to provide a dynamic indication of the position of the radiology signs on the 3D image by means of markers. The use of dynamic viewing draws the practitioner's attention to the zones of clinical interest. The disclosed algorithm thus highlights all the radiology signs in the 3D image of the breast.
Owner:GENERAL ELECTRIC CO

Polypeptides KXK and Their Use

ActiveUS20110033507A1Appropriate useHighly pharmaceutically and/or cosmetically effectiveCosmetic preparationsMake-upArginineBiotin
The invention concerns polypeptides of the general formula (I): A-(Xaa)n-Lys-X-Lys-B wherein: i) A is —NH2, NH3+, or NH-D (D is an acyl group being biotin or an alkyl chain (C2-C22)), H) B is H, O− OR1 or NR2R3 and R1, R2 and R3 independently either: H or an alkyl chain (C1-C24), iii) (Xaa)n is an amino acid chain including any amino acid natural or not, excluding arginine and lysine, iv) “n” is between 0-3, and v) X is either a chain of two any amino acids (Xaa1Xaa2), which may be the same or different, excluding arginine, lysine and excluding Xaa1Xaa2=Thr-Thr, Gly-His and Glu-His, or X is a spacer selected among beta-alanyl, 5-amino-valeroyl, 4-amino-cyclohexanoyl, 4-amino-butyroyl, 6-amino-caproyl and derivatives thereof. More particularly, the invention concerns polypeptides of formula (I) wherein “n” is 0 and with the formula: A-Lys-X-Lys-B; A, X and B being defined herein. Compositions containing at least one of said polypeptides and their use.
Owner:SEDERMA SA

Methods for treating skin

Provided are methods of treating skin with at least two alternating treatment modalities to improve the health and / or diminish signs of aging. Some methods according to the present invention may comprise topically applying at least two separate compositions, in a sequential, rotating, or alternating fashion to overcome adaptation, tolerance, or sensitization phenomena.
Owner:AVON PROD INC

Histamine binding protein

InactiveUS20110152171A1Reduction TIMP-Improve the level ofSenses disorderPeptide/protein ingredientsHistamine bindingHistamine
The invention relates to histamine binding proteins. The invention also relates to the use of such histamine binding proteins in the treatment and prevention of diseases.
Owner:VARLEIGH IMMUNO PHARMA VIP

Composition for treating skin barrier and reducing acne

A composition for applying to skin suffering from acne to treat the acne, the composition comprising an extract of Malva neglecta. The Malva neglecta increases ceramide production at the area of skin affected by acne to treat and / or improve the acne. Additionally, the composition may include cholesterol.
Owner:JOHNSON & JOHNSON CONSUMER COPANIES

Cosmetic foundation

The present invention provides a cosmetic mineral foundation, which is a loose powder, comprising Unfermented Green Rooibos Extract (Aspalathus Linearis Leaf), which functions as an antioxidant, and helps reduce the appearance of fine lines and wrinkles, and diminish signs of aging caused by free-radical damage. The foundation is gentle for all skin types, can be used daily, and provides effective anti-aging treatment as well as quality skin coverage.
Owner:GUTHY-RENKER

Methods for treating skin barrier and reducing acne

A method of treating acne by applying to the skin an extract of Malva neglecta topically to the area of skin affected by acne to increase ceramide production at the area of skin affected by acne to treat and / or improve the acne. Additionally, cholesterol may also be applied to the area of skin along with the Malva neglecta to treat and / or improve the acne.
Owner:JOHNSON & JOHNSON CONSUMER COPANIES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products